Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Comcast
CMCSA
|
+$1.02B |
| 2 |
Travelers Companies
TRV
|
+$983M |
| 3 |
TC Energy
TRP
|
+$886M |
| 4 |
Xcel Energy
XEL
|
+$761M |
| 5 |
General Mills
GIS
|
+$716M |
Top Sells
| 1 |
Enbridge
ENB
|
+$1.75B |
| 2 |
Boeing
BA
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.07B |
| 5 |
Amazon
AMZN
|
+$797M |
Sector Composition
| 1 | Technology | 21.35% |
| 2 | Healthcare | 17.96% |
| 3 | Communication Services | 14.6% |
| 4 | Financials | 13.2% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
351
Autolus Therapeutics
AUTL
$351M
| $19.6M | 0.01% |
1,222,688
| – | – |
|
352
Vodafone
VOD
$28.4B
| $19.6M | 0.01% |
+1,242,355
| New | +$19.6M |
|
|
CVA
353
DELISTED
Covanta Holding Corporation
CVA
| $19.4M | 0.01% |
2,019,800
| – | – |
|
354
TotalEnergies
TTE
$135B
| $19.3M | 0.01% |
+494,946
| New | +$19.3M |
|
355
Pool Corp
POOL
$12.1B
| $18.7M | 0.01% |
68,900
| – | – |
|
|
NCNA
356
NuCana
NCNA
$8.59M
| $18.2M | 0.01% |
674
| – | – |
|
|
NFH
357
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $18.1M | 0.01% |
2,191,400
+63,400
| +3% | +$525K |
|
|
SAGE
358
DELISTED
Sage Therapeutics
SAGE
| $18.1M | 0.01% |
435,311
-3,241,036
| -88% | -$135M |
|
359
Newell Brands
NWL
$2.45B
| $18.1M | 0.01% |
1,137,800
| – | – |
|
360
Wyndham Hotels & Resorts
WH
$6.42B
| $16.6M | 0.01% |
390,000
-56,900
| -13% | -$2.43M |
|
|
AMTI
361
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $16.5M | 0.01% |
+655,300
| New | +$16.5M |
|
362
Endava
DAVA
$513M
| $15.6M | 0.01% |
322,200
| – | – |
|
363
Cousins Properties
CUZ
$4.9B
| $14.6M | ﹤0.01% |
489,353
-110,179
| -18% | -$3.29M |
|
364
Cannae Holdings
CNNE
$1.12B
| $14.5M | ﹤0.01% |
353,987
+211,409
| +148% | +$8.69M |
|
365
Fabrinet
FN
$12.8B
| $13.6M | ﹤0.01% |
+218,080
| New | +$13.6M |
|
366
PPL Corp
PPL
$26.6B
| $13.5M | ﹤0.01% |
523,133
| – | – |
|
|
SILK
367
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $13.4M | ﹤0.01% |
320,600
| – | – |
|
368
Xenon Pharmaceuticals
XENE
$2.78B
| $13.2M | ﹤0.01% |
1,055,726
| – | – |
|
|
ADAP
369
Adaptimmune Therapeutics
ADAP
$17.7M
| $13.2M | ﹤0.01% |
1,321,200
| – | – |
|
370
Sandstorm Gold
SAND
$3.56B
| $13.1M | ﹤0.01% |
1,361,300
| – | – |
|
|
LVGO
371
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $13M | ﹤0.01% |
+172,700
| New | +$13M |
|
|
NLSN
372
DELISTED
Nielsen Holdings plc
NLSN
| $12.7M | ﹤0.01% |
856,400
| – | – |
|
373
Fox Class A
FOXA
$26.2B
| $12.7M | ﹤0.01% |
473,666
-11,156,675
| -96% | -$299M |
|
374
Fair Isaac
FICO
$37.3B
| $12.2M | ﹤0.01% |
29,100
-12,600
| -30% | -$5.27M |
|
375
Halliburton
HAL
$18.6B
| $11.9M | ﹤0.01% |
920,282
-3,190,361
| -78% | -$41.4M |
|